COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 175.8 | 1 | 0165-0509 | 17.93 | 509.60 | 362 | 72.08 | 0.875 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2463.9 | 1 | 0166-0510 | 188.53 | 509.87 | 383 | 71.84 | 0.933 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 422.3 | 1 | 0167-0512 | 606.62 | 511.74 | 393 | 76.08 | 0.853 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 273.2 | 1 | 0168-0513 | 745.60 | 513.60 | 376 | 73.01 | 0.886 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 329.3 | 1 | 0169-0513 | 487.28 | 512.82 | 395 | 76.08 | 0.857 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 191.8 | 1 | 0170-0517 | 895.51 | 516.63 | 393 | 75.50 | 0.866 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 201.6 | 1 | 0171-0521 | 326.02 | 521.07 | 373 | 71.60 | 0.914 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 202.9 | 1 | 0172-0523 | 118.03 | 523.23 | 386 | 72.18 | 0.931 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 265.7 | 1 | 0173-0525 | 289.17 | 524.87 | 410 | 76.67 | 0.877 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 242.2 | 1 | 0174-0525 | 420.66 | 525.54 | 395 | 76.08 | 0.857 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 246.3 | 1 | 0175-0528 | 648.78 | 528.16 | 396 | 74.43 | 0.898 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 189.9 | 1 | 0176-0530 | 163.13 | 530.49 | 391 | 74.67 | 0.881 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 342.1 | 1 | 0177-0530 | 771.34 | 530.25 | 390 | 73.01 | 0.919 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.5 | 1 | 0178-0533 | 199.57 | 533.05 | 381 | 73.60 | 0.884 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 207.3 | 1 | 0179-0540 | 385.59 | 540.73 | 417 | 78.91 | 0.842 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 228.4 | 1 | 0180-0539 | 543.36 | 539.82 | 398 | 75.84 | 0.870 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 172.1 | 1 | 0181-0547 | 897.72 | 547.42 | 433 | 85.40 | 0.746 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 241.1 | 1 | 0182-0544 | 40.20 | 544.43 | 338 | 70.67 | 0.850 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 750.8 | 1 | 0183-0548 | 473.27 | 547.35 | 620 | 101.40 | 0.758 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 338.4 | 1 | 0184-0562 | 275.66 | 562.66 | 620 | 92.91 | 0.903 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 262.0 | 1 | 0185-0571 | 557.83 | 571.47 | 817 | 113.78 | 0.793 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 287.8 | 1 | 0186-0565 | 658.42 | 565.82 | 393 | 73.84 | 0.906 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 259.4 | 1 | 0187-0570 | 94.36 | 570.37 | 340 | 68.18 | 0.919 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 254.7 | 1 | 0188-0570 | 756.96 | 569.72 | 404 | 76.43 | 0.869 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 165.6 | 1 | 0189-0573 | 890.54 | 574.05 | 415 | 78.43 | 0.848 |